Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 223 results for "orchid pharma"

Orchid Pharma to allocate shares worth Rs 92 cr to promoter gr...

Orchid Pharma to allocate equity shares to Orchid Healthcare Private Ltd, a promoter Group company, to the tune of Rs 92.17 crore. This is to comply with the requirements to Corporate Debt Restructuring programme approved by the Consortium of ... Business Standard, 20 hours ago

7 images for orchid pharma

Bio Spectrum Asia, 3 weeks ago
Business Standard India, 2 months ago
Money Control, 4 months ago
Business Standard, 4 months ago
Business Standard, 4 months ago
Business Standard, 4 months ago
Business Standard India, 5 months ago

07.15.14 -- Lilly and Yabao To Partner For Diabetes Therapy; Hospira Acquires Orchid

SPONSOR Outsourced Pharma West Conference And Exhibition November 10 and 11, 2014 | Hyatt Regency, San Francisco, CA • Who should attend? Pharma and biopharm executives who form and manage outsourcing partnerships. ...
 Pharmaceutical Online2 weeks ago Hospira completes buy of Orchid's API production and R&D facility  Pharma Letter3 weeks ago Orchid completes Hospira deal, implementation of CDR package  Business Standard India3 weeks ago Hospira Completes Acquisition of Orchid's Active Pharmaceutical Ingredient Manufacturing and R&D Facility  FirstWord Pharma3 weeks ago

Orchid Pharma promoters to up by stake by 13 %

Promoters of Chennai-based Orchid Chemicals & Pharmaceuticals Ltd to increase their stake to 45 per cent. Today's company's Board of Directors has approved the issue of shares to Promoters on a preferential basis pursuant to the conditions of CDR ...
 Business Standard India2 weeks ago Rising Sales & Falling Profits  PharmaBiz2 weeks ago Indian 100 pharma players post single digit net profit growth of 6% during 2013-14  PharmaBiz3 weeks ago Sensex, Nifty flat; Sun Pharma slips 2%, Axis Bank up 1%  Moneycontrol.com1 month ago
Bio Spectrum Asia

India's Orchid Pharma completes debt recast

Singapore: Indian company, based in Chennai, Orchid Chemicals and Pharmaceuticals has said that it completed the debt recast scheme that it had initiated last year. As per the process, Orchid will pay back dues of ₹ 2,866 crore to a consortium ...
 Bio Spectrum Asia3 weeks ago Orchid Pharma completes implementing corporate debt restructuring package  Times of India3 weeks ago Orchid Pharma completes process of debt recast  Business Line3 weeks ago ORCHID CHEMICALS & PHARMACEUTICALS : Pharma completes implementing corporate debt restructuring package  4 Traders3 weeks ago

Orchid receives USFDA approval for Eszopiclone Tablets ANDA

Orchid Chemicals & Pharmaceuticals, the Chennai-based pharma major, has received approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Eszopiclone Tablets, 1 mg, 2 mg, and 3 mg strengths. Orchid Chemicals & Pharmaceuticals is a ...
 Indian-Commodity1 month ago Orchid Chemicals rallies over 8% on USFDA nod for Eszopiclone tablets  Economic Times1 month ago Orchid Chemicals rises on USFDA approval for Eszopiclone tablet  Business Standard India1 month ago Orchid surges on receiving USFDA approval for Eszopiclone Tablets ANDA  Indian-Commodity1 month ago

Buzzing Stocks: ICRA, Sun Pharma, Atul, Auto, USL, IFCI

ICRA, Sun Pharma, Atul, Auto, USL, IFCI, Orchid Chemicals are top buzzing stocks of the day.
 Money Control1 month ago

Debt Tribunal clears decks for $218 mn Orchid-Hospira deal

The Debt Recovery Tribunal (DRT) in Chennai cleared the decks for Orchid Pharma to transfer its pencillin and penems API business along with some facilities to the US-based Hospira over a $200 million deal which was announced in August, 2012. The ...
 Business Standard India1 month ago Decks cleared for $218-million orchid pharma-hospira deal  4 Traders1 month ago

No stay on Orchid Pharma loan rejig

The interim order was issued on an application filed by Serum Institute, Cyrus Poonawalla and his firms
 Business Standard2 months ago

Orchid seals Hospira deal

The completion of BTA and CDR implementation are expected to help Orchid Pharma to rebuild the business
 Business Standard3 weeks ago

Chinese Pharmaceutical Market Commercial & Strategic Developments to 2024 adds "The Chinese Pharmaceutical Market to 2024 - Commercial & Strategic developments in the Chinese Pharmaceutical Market to 2024" report to its research database. From 2008 to 2013, China's OTC drugs market reported an ...
 Individual.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less